Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2026-01-02 @ 1:16 PM
Study NCT ID:
NCT03979456
Status:
UNKNOWN
Last Update Posted:
2021-04-19
First Post:
2019-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS
Sponsor:
Karolinska Institutet
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
EudraCT 2018-000721-31
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None